Genomic organization of human and mouse genes for vascular endothelial growth factor C.
about
Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesisCOX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancerGambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathwayThe vascular endothelial growth factor (VEGF) family: angiogenic factors in health and diseaseRole of hypoxia and vascular endothelial growth factors in lymphangiogenesisUp-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathwayTo NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate RegulatorBmi-1 promotes glioma angiogenesis by activating NF-κB signalingThe transcription factor Net regulates the angiogenic switchCharacterization of novel VEGF (vascular endothelial growth factor)-C splicing isoforms from mouseVEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.Effect of inflammatory cytokines on the expression of the vascular endothelial growth factor-C.Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models.Hypothesis: thalidomide embryopathy-proposed mechanism of action.Crotepoxide chemosensitizes tumor cells through inhibition of expression of proliferation, invasion, and angiogenic proteins linked to proinflammatory pathwayComparative expression of vascular endothelial growth factor family members, VEGF-B, -C and -D, by normal human keratinocytes and fibroblasts.Analysis of the IKKbeta/NF-kappaB signaling pathway during embryonic angiogenesis.Ubiquitin-conjugating enzyme complex Uev1A-Ubc13 promotes breast cancer metastasis through nuclear factor-кB mediated matrix metalloproteinase-1 gene regulation.miR-301a as an NF-κB activator in pancreatic cancer cells.Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cellsNF-kappaB and cancer: how intimate is this relationshipSignal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.Oxidative stress in retinal pigment epithelium cells increases exosome secretion and promotes angiogenesis in endothelial cells.Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation.Increased lymphangiogenesis in joints of mice with inflammatory arthritisThe role of the VEGF-C/VEGFRs axis in tumor progression and therapy.Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large?Ulinastatin exerts synergistic effects with taxotere and inhibits invasion and metastasis of breast cancer by blocking angiogenesis and the epithelial-mesenchymal transition.Transcription factors as therapeutic targets in lymphoid malignancies.A role for NF-kappaB-dependent gene transactivation in sunburn.Triptolide Combined with Radiotherapy for the Treatment of Nasopharyngeal Carcinoma via NF-κB-Related Mechanism.Resveratrol Suppresses Expression of VEGF by Human Retinal Pigment Epithelial Cells: Potential Nutraceutical for Age-related Macular Degeneration.RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cellsChitin hydrolysate stimulates VEGF-C synthesis by MDA-MB-231 breast cancer cells.Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy.Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis.VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism.A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity.Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma.Upregulation of VEGF-C by androgen depletion: the involvement of IGF-IR-FOXO pathway.
P2860
Q22010852-C72DC755-0BA2-4F53-B743-ADE39E4056F9Q24651871-5065BF47-D8D2-41AB-85E8-7819E8845009Q24678660-0405908C-B97D-45FF-9E12-39C690C19225Q24796165-295AA2E0-BF70-4955-86D4-C72DD4573D7CQ26745683-CB47C4D4-6C07-4C28-9BAE-39B36D4123D5Q28216853-57764351-13FB-4C75-A836-2A686729FD6CQ28386593-9FD993F0-E505-4F7C-8B2D-43C93E4DAB5BQ28485863-5DAAB25B-BFBF-4EE0-905E-4F33D5AA3822Q28504967-F841A488-88DF-4BF9-9883-C88392E029DAQ28588181-CD743287-E52A-4006-B339-7EDC54627FB0Q33615188-42D3726D-E20F-42ED-AE7F-E2931DEB19B7Q33723780-446CBCA4-5333-4C02-B795-8FA636DD82F8Q33795121-8C6F190E-AEB8-4ADA-B872-AB2C19D78916Q33831075-82C05394-A503-4E3F-ABAC-0D2F25D3958CQ34094406-D19BAB1D-FA34-4638-8AE8-3739409220B7Q34304087-950528B7-1AA5-468F-B292-A6D8A1AE437AQ34389111-BE510C1C-BA18-4F42-8711-887DB64F630BQ34468776-7DF9EC5A-65E8-4EB1-B877-5F7F224DD8CAQ34485753-3FA4771A-F024-460E-8A5B-7466FC23663BQ35011812-883727AC-C321-447D-8CDF-94FAEE2A9026Q35143597-EB6E9D18-568D-49E6-A9EA-4AE9197D5BD6Q35166852-634EFF42-3623-4190-87BB-6C3F8947AC55Q35964977-E95D6F10-2873-4ADC-969B-E07BA1221184Q36274684-E8395BBB-4A85-4979-8666-EBDEAEEB31FEQ36465469-D744DA93-BAAE-491E-8F6C-A90E32D32151Q36589860-E78FBB6B-B8C3-43AD-A4CD-FCFDB5BCF6ABQ36617731-95C614E4-1C10-41FF-8371-54B30D813F80Q36737982-125DAE12-17FD-4594-AAFF-7F4FD4884874Q37008654-100EDAA9-7332-400A-97BB-4447930BB077Q37202396-90964864-F4D8-4DC3-974E-5AAA9427F1F2Q37534942-53B958E5-D7A9-4B67-AA22-2999A7E79BDAQ37665378-5E98AB54-2BA8-432D-9218-840E19121434Q37774686-547F0D88-6BF5-4266-9D58-6E987D5B051DQ38339742-E897FF6A-77D9-4823-A6A1-5DF3885C4862Q38624686-FB95AB96-3C7E-4470-B3B9-E4B7BFD3AF0BQ38866652-E783116A-E87A-4308-B9D4-68C161F8F054Q39647223-256F02CC-0724-456B-8E30-F6218F7E81B1Q39777243-73750706-D5B8-4C2F-B414-49B10E226495Q40399687-CA81A739-7C10-4BBA-BC79-8C4540C36443Q40421578-992E658A-2958-4D76-BD26-F13DD4A07258
P2860
Genomic organization of human and mouse genes for vascular endothelial growth factor C.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Genomic organization of human and mouse genes for vascular endothelial growth factor C.
@en
type
label
Genomic organization of human and mouse genes for vascular endothelial growth factor C.
@en
prefLabel
Genomic organization of human and mouse genes for vascular endothelial growth factor C.
@en
P2093
P2860
P50
P356
P1476
Genomic organization of human and mouse genes for vascular endothelial growth factor C
@en
P2093
P2860
P304
25176-25183
P356
10.1074/JBC.272.40.25176
P407
P577
1997-10-01T00:00:00Z